Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Vaccines for cocaine abuse.

Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR.

Hum Vaccin. 2009 Apr;5(4):194-9. Epub 2009 Apr 20. Review.

2.

The search for medications to treat stimulant dependence.

Kampman KM.

Addict Sci Clin Pract. 2008 Jun;4(2):28-35.

3.

Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial.

Bickel WK, Marsch LA, Buchhalter AR, Badger GJ.

Exp Clin Psychopharmacol. 2008 Apr;16(2):132-43. doi: 10.1037/1064-1297.16.2.132.

4.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Mattick RP, Kimber J, Breen C, Davoli M.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002207. doi: 10.1002/14651858.CD002207.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD002207.

PMID:
18425880
5.

Sustained-release naltrexone: novel treatment for opioid dependence.

Comer SD, Sullivan MA, Hulse GK.

Expert Opin Investig Drugs. 2007 Aug;16(8):1285-94. Review.

PMID:
17685876
6.

New developments in the pharmacotherapy of cocaine abuse.

Preti A.

Addict Biol. 2007 Jun;12(2):133-51. Review.

PMID:
17508985
7.

Improved adherence with contingency management.

Rosen MI, Dieckhaus K, McMahon TJ, Valdes B, Petry NM, Cramer J, Rounsaville B.

AIDS Patient Care STDS. 2007 Jan;21(1):30-40.

PMID:
17263651
8.

Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S.

Drug Alcohol Depend. 2007 Apr 17;88(1):54-63. Epub 2006 Oct 23.

9.

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.

Johansson BA, Berglund M, Lindgren A.

Addiction. 2006 Apr;101(4):491-503. Review.

PMID:
16548929
10.

Vaccine pharmacotherapy for the treatment of cocaine dependence.

Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR.

Biol Psychiatry. 2005 Jul 15;58(2):158-64.

PMID:
16038686
11.

Evaluation of an injection depot formulation of buprenorphine: placebo comparison.

Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE.

Addiction. 2004 Nov;99(11):1439-49.

PMID:
15500597
12.

Therapeutic vaccines for substance dependence.

Haney M, Kosten TR.

Expert Rev Vaccines. 2004 Feb;3(1):11-8. Review.

PMID:
14761239
13.

A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.

Seal KH, Kral AH, Lorvick J, McNees A, Gee L, Edlin BR.

Drug Alcohol Depend. 2003 Aug 20;71(2):127-31.

PMID:
12927650
14.

Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

Petry NM, Martin B.

J Consult Clin Psychol. 2002 Apr;70(2):398-405.

PMID:
11952198
15.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
16.

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ.

Arch Gen Psychiatry. 2001 Aug;58(8):755-61.

17.

Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention.

Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, O'Malley SS, Dieckhaus KD, Rounsaville BJ.

J Gen Intern Med. 2000 Dec;15(12):841-7.

18.

Improvement in naltrexone treatment compliance with contingency management.

Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR.

Drug Alcohol Depend. 1999 Apr 1;54(2):127-35.

PMID:
10217552
19.

Monetary versus nonmonetary incentives for TB skin test reading among drug users.

Malotte CK, Hollingshead JR, Rhodes F.

Am J Prev Med. 1999 Apr;16(3):182-8.

PMID:
10198656

Supplemental Content

Support Center